1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,360 | 3,600 | 15:14 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.01. | CCBI Lifts WUXI XDC's TP to $43 for Brighter Fundamentals & Outlook | 1 | AASTOCKS | ||
| 15.01. | BRIEF: WuXi XDC's revenue, profit jump in 2024 | 1 | Bamboo Works | ||
| 15.01. | WUXI XDC Forecasts NP to Grow 2.6x YoY Last Yr | 1 | AASTOCKS | ||
| 15.01. | WUXI XDC (02268): POSITIVE PROFIT ALERT | 1 | HKEx | ||
| 14.01. | WuXi AppTec's Shares Jump After Selling 7.2% Stake in WuXi XDC for USD312 Million | 4 | Yicai Global | ||
| 13.01. | WUXI XDC Plummets 6%+; Shareholder STA Pharmaceutical Cuts Stake | 1 | AASTOCKS | ||
| 06.01. | M Stanley Likes HANSOH PHARMA, WUXI XDC, ALI HEALTH in Biopharma, CRO/CDMO, Internet Health | 7 | AASTOCKS | ||
| 21.11.24 | WUXI XDC (02268): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 2 | HKEx | ||
| WUXI XDC Aktie jetzt für 0€ handeln | |||||
| 21.11.24 | WUXI XDC (02268): (1) CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS; AND (2) CHANGE IN COMPOSITION OF BOARD COMMITTEES | 2 | HKEx | ||
| 25.10.24 | WUXI XDC (02268): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON OCTOBER 25, 2024 | 2 | HKEx | ||
| 24.10.24 | Neues Speziallabel für Krebsstudien: Für eine klinische Krebsstudie nutzt WuXi XDC ein spezielles Lichtschutzlabel ... | 2 | packaging journal | ||
| 23.10.24 | WuXi XDC Taps Schreiner MediPharm for ADC Drug Label Solution | 6 | Contract Pharma | ||
| 09.10.24 | WUXI XDC (02268): FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, OCTOBER 25, 2024 | 1 | HKEx | ||
| 09.10.24 | WUXI XDC (02268): NOTICE OF EXTRAORDINARY GENERAL MEETING | 2 | HKEx | ||
| 09.10.24 | WUXI XDC (02268): REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE ANTIBODIES MASTER SERVICES AGREEMENT AND NOTICE OF EXTRAORDINARY ... | 1 | HKEx | ||
| 04.10.24 | WUXI XDC (02268): CLOSURE OF REGISTER OF MEMBERS | - | HKEx | ||
| 30.09.24 | WUXI XDC (02268): GRANT OF RESTRICTED SHARES UNDER THE 2024 SHARE SCHEME | 1 | HKEx | ||
| 30.09.24 | WUXI XDC (02268): FURTHER DELAY IN DESPATCH OF CIRCULAR | 1 | HKEx | ||
| 26.09.24 | WUXI XDC (02268): INTERIM REPORT 2024 | 1 | HKEx | ||
| 16.09.24 | WUXI XDC (02268): DELAY IN DESPATCH OF CIRCULAR | - | HKEx |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TEMPUS AI | 61,86 | 0,00 % | Tempus AI (TEM) Acquires Ambry Genetics in $600M Precision Medicine Push | ||
| IMMUNOVANT | 20,910 | 0,00 % | Here's Why Immunovant, Inc. (IMVT) Will Double in 2025 | ||
| SPRINGWORKS THERAPEUTICS | 38,400 | 0,00 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 20, 2025 | ||
| ADMA BIOLOGICS | 16,900 | 0,00 % | Engaging In Insider Activity, Kaitlin M. Kestenberg-Messina At ADMA Biologics Exercises Options Worth $28K | ||
| AVIDITY BIOSCIENCES | 33,340 | 0,00 % | Avidity Biosciences, Inc.: Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025 | Accelerated approval path confirmed for del-zota; Biologics License Application (BLA) submission planned for year end 2025
On track to complete enrollment in del-desiran... ► Artikel lesen | |
| JANUX THERAPEUTICS | 41,310 | 0,00 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 38,980 | 0,00 % | Harmony Biosciences Stock Scores 80-Plus RS Rating | ||
| 89BIO | 10,750 | 0,00 % | Hedge Fund and Insider Trading News: Ken Griffin, Paul Singer, Greenlight Capital, Balyasny Asset Management, Ashland Inc (ASH), 89bio Inc (ETNB), and More | ||
| DYNE THERAPEUTICS | 14,790 | 0,00 % | Dyne's Myotonic Secures FDA's Fast Track Designation For Myotonic Dystrophy Type 1 Therapy | WASHINGTON (dpa-AFX) - Dyne Therapeutics, Inc. (DYN), Tuesday announced that the U.S. Food and Drug Administration has granted Fast Track designation for DYNE-101 for the treatment of myotonic... ► Artikel lesen | |
| QIAGEN | 42,210 | +0,42 % | Qiagen NV-Aktie kann Vortagsniveau nicht halten (42,58 €) | An der Börse notiert die Aktie von Qiagen NV derzeit ein wenig leichter. Der jüngste Kurs betrug 42,58 Euro. Heute hat sich am Aktienmarkt das Wertpapier von Qiagen NV zwischenzeitlich um 0,73 Prozent... ► Artikel lesen | |
| EVOTEC | 8,800 | +5,33 % | Commerzbank, Deutz, Evotec, Renk, Shell, Valneva - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 7,610 | 0,00 % | How Is The Market Feeling About Recursion Pharmaceuticals? | ||
| BEAM THERAPEUTICS | 25,750 | 0,00 % | (BEAM) - Analyzing Beam Therapeutics' Short Interest | ||
| EDGEWISE THERAPEUTICS | 29,500 | 0,00 % | Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the third quarter of 2024... ► Artikel lesen | |
| ARVINAS | 18,050 | 0,00 % | Arvinas stock plunges to 52-week low at $16.95 amid market challenges |
Das Unternehmen WUXI XDC CAYMAN INC kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 3,600 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WUXI XDC CAYMAN INC finden Sie auf Wallstreet Online.
